Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20050998HPVENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS20065483HPVENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44031243HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44008044HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44020668HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TVIS44036283HTLV-1ENSG00000122025.15protein_codingFLT3YesNo2322P36888
TCGA Plot Options
Drug Information
GeneFLT3
DrugBank IDDB08901
Drug NamePonatinib
Target IDBE0000147
UniProt IDP36888
Regulation Typeinhibitor
PubMed IDs23430109
CitationsSmith CC, Lasater EA, Zhu X, Lin KC, Stewart WK, Damon LE, Salerno S, Shah NP: Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD. Blood. 2013 Apr 18;121(16):3165-71. doi: 10.1182/blood-2012-07-442871. Epub 2013 Feb 21.
GroupsApproved; Investigational
Direct ClassificationBenzanilides
SMILESCN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1
PathwaysPonatinib Inhibition of BCR-ABL
PharmGKBPA165980594
ChEMBLCHEMBL1171837